Work

Recent progress in TGF-β inhibitors for cancer therapy

Year: 2020
Type: review
Abstract: Transforming growth factor-β (TGF-β) is a multifunctional cytokine that is involved in proliferation, metastasis, and many other important processes in malignancy. Inhibitors targeting TGF-β have been considered by pharmaceutical companies for cancer therapy, and some of them are in clinical trial now. Unfortunately, several of these programs have recently been relinquished, and most companies that remain in the contest are progressing slowly and cautiously. This review summarizes the TGF-β signal transduction pathway, its roles in oncogenesis and fibrotic diseases, and advancements in antibodies and small-molecule inhibitors of TGF-β.
Language: English
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W3112064419
FWCI: 2.325
Cites: 116
Cited by: 219
Related to: 10